It’s February 2020 and drugmaker Moderna’s sprinting ahead – its Covid vaccine is already poised to enter human trials.But Moderna and its rivals know plenty of vaccines never make it out of trials alive. It’s also going to take a lot of manufacturing muscle to inoculate the world. All of which costs a lot of moolah.And if the vaccine makers can’t secure a deep-pocketed partner in time, they’re going to get disqualified from the race.Listen to new episodes 1 week early and to all episodes ad free with Wondery+. Join Wondery+ for exclusives, binges, early access, and ad free listening. Available in the Wondery App https://wondery.app.link/businesswars.Support us by supporting our sponsors!See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.